Johnson & Johnson to resume European vaccine rollout

Johnson & Johnson will restart shipments to the European Union, Norway and Iceland. Photo: AP Photo/Mary Altaffer

Johnson & Johnson (J&J) will resume rolling out its one-shot Covid-19 vaccine after Europe's medical regulator said the benefits of the J&J jab outweigh the risk.

The European Medicines Agency (EMA) on Tuesday recommended adding a safety warning about rare blood clots with low blood platelet count to the vaccine’s product label and ultimately concluded there were far more risks in contracting the virus than there would be taking the J&J vaccine.